Your browser doesn't support javascript.
loading
Incidental finding of [99mTc]Tc-MIBI uptake in a post-radiotherapy breast without recurrence of cancer.
Cacko, Marek; Józwik-Plebanek, Katarzyna; Wnuk, Jacek; Teresinska, Anna.
Afiliação
  • Cacko M; Department of Nuclear Medicine, National Institute of Cardiology, Warsaw, Poland.
  • Józwik-Plebanek K; Department of Nuclear Medicine, National Institute of Cardiology, Warsaw, Poland.
  • Wnuk J; Department of Nuclear Medicine, National Institute of Cardiology, Warsaw, Poland.
  • Teresinska A; Department of Nuclear Medicine, National Institute of Cardiology, Warsaw, Poland. ateresinska@ikard.pl.
Nucl Med Rev Cent East Eur ; 26(0): 156-157, 2023.
Article em En | MEDLINE | ID: mdl-38966961
ABSTRACT
The oncophilic nature of [99mTc]Tc-MIBI makes this radiopharmaceutical useful in cancer diagnostics, with particular emphasis on breast cancer. Increased uptake of [99mTc]Tc-MIBI in tests performed for non-oncological indications always raises the suspicion of its neoplasmatic character and requires further clinical diagnostics, which is especially justified in patients with a previous history of cancer. However, the presented case illustrates that focally increased uptake of [99mTc]Tc-MIBI is not always associated with the presence of cancer cells and may result from post-therapeutic changes.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article